Abstract:Background: Vaccination provides protection against infection by inducing VNAs mainly against RABV surface GP. The measurement of VNAs to RABV is commonly used to assess the level of immunity in humans and animals after vaccination. A VNA titer of >= 0.5 IU/mL of sera indicates adequate response to vaccination. Here, we report the development and validation of a RABV GP serology ELISA kit for semi-quantitative measurement of VNA titers in sera of vaccinated human subjects. Methods: Using a recombinant RABV GP expressed in mammalian cells as the capture antigen, the ELISA method was established using HuMAb NM57 reference initially and HRIG reference subsequently. The limit of detection (LOD), linear range, reproducibility, and precision of the method were examined. Specificity and sensitivity were established to assess the diagnostic accuracy. Results: RABV GP for ELISA plate coating and optimal dilution of human serum sample was 1 mu g/mL and 1:20, respectively. Multiple assays were carried out by different technicians at different laboratories for assay standardization. Using the HRIG reference, the LOD was found to be 0.02-0.06 IU/mL and the linear range was 0.2-10.0 IU/mL. The inter-assay CVs were in the range of 6.60-10.79%, indicating the reproducibility. None of the 12 known negative human sera, tested positive by ELISA, highlighting the specificity. A total of 415 unknown positive human sera were double-blind tested by the RFFIT and ELISA. The VNA titer cut-off value of ELISA was set at 1.5 IU/mL to ensure no false-positive. The diagnostic specificity and sensitivity were 100% and 91.1%, respectively. Conclusions: The validation data characterize this ELISA as a suitable method for semi-quantitative measurement of VNA titers in human serum samples to assess vaccination status. The ELISA kit can offer simplicity, speed, low cost and high throughput, making it a practical tool for monitoring the immune response following vaccination. (C) 2019 Elsevier Ltd. All rights reserved.

Sensitive, Semiquantitative, and Portable Nucleic Acid Detection of Rabies Virus Using a Personal Glucose Meter

A recombinase polymerase amplification assay for rapid detection of rabies virus

[Study on the Feasibility of a Cell-Culture Inoculation Test in the Detection and Isolation of Street Rabies Virus].

Evaluation of Monoclonal Antibody-Based Direct, Rapid Immunohistochemical Test for Rabies Diagnosis.

Developing a detection method for rabies virus neutralizing antibodies using pseudotype technique

Review of Detection and Quantification of Rabies Virus Antibodies.

Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system

Predicting the presence and titer of rabies virus neutralizing antibodies from low-volume serum samples in low-containment facilities

A rapid one-step immunochromatographic test strip for rabies detection using canine serum samples

Quantitative and Selective DNA Detection with Portable Personal Glucose Meter Using Loop-Based DNA Competitive Hybridization Strategy

An Exploration of Nucleic Acid Liquid Biopsy Using a Glucose Meter.

Rabies Virus Glycoprotein Serology ELISA for Measurement of Neutralizing Antibodies in Sera of Vaccinated Human Subjects.

Using Commercially Available Personal Glucose Meters for Portable Quantification of DNA.

Development and validation of a real-time PCR assay for the diagnosis of rabies virus Philippine strain in non-brain samples

Using a Glucose Meter to Quantitatively Detect Disease Biomarkers Through a Universal Nanozyme Integrated Lateral Fluidic Sensing Platform.

Evaluation of six TaqMan RT-rtPCR kits on two thermocyclers for the reliable detection of rabies virus RNA

Enzyme immunoassay for rabies antibody in hybridoma culture fluids and its application to differentiation of street and laboratory strains of rabies virus

Portable and Quantitative Detection of Protein Biomarkers and Small Molecular Toxins Using Antibodies and Ubiquitous Personal Glucose Meters.

Establishment and application of a noval CVS-11 pseudovirus-based assay for detection of neutralizing antibody against rabies virus

Toward establishing a rapid constant temperature detection method for canine parvovirus based on endonuclease activities

Rapid, sensitive, and visual detection of pseudorabies virus with an RPA-CRISPR/EsCas13d-based dual-readout portable platform